Skip to main content
ConductScienceScienceDex

ScienceDex / Researcher record

Boaz Pirie Levi

From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.

FY2026 NIH rank #11,035
Unclaimed recordClaim profile
  • Early Career

NIH Funding · FY2026

Linked Award Amount
$1.9M
Full award amounts, FY2026
Award Records
2
Records listing this PI
Award-Linked Rank
#11,035
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2024$901,9321#16,993
2025$1,177,6352#13,918
2026$1,893,0562#11,035

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20241 record
  2. FY20252 records
  3. FY2026 · selected2 records

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Boaz Pirie Levi. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

NINDS

National Institute of Neurological Disorders and Stroke

$1.9M

2 awards · administering

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 8960090Search this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.

FY2026 award records by amount

NIH award records listing Boaz Pirie Levi as a PI. Multi-PI records show the full award amount for context.

  • 1R44NS145930-01A1R44Contact PI
    Cell class-specific AAV gene therapy for SLC6A1-related neurodevelopmental disorder
    Epicure Therapeutics, Inc.
    $1.5M
    award amount
  • 5R61NS138832-02R61Contact PI
    Development of an oligonucleotide therapeutic for Dravet syndrome
    Allen Institute
    $393.2K
    award amount

Award organizations

Organizations that administered FY2026 awards listing Boaz Pirie Levi as a PI.

Epicure Therapeutics, Inc.
WA
$1.5M
1 grant
Allen Institute
WA
$393.2K
1 grant

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Epicure Therapeutics, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2025
    $1M Cumulative Funding
  4. 2025
    $2M Cumulative Funding
  5. 2025
    Multi-Institutional Research
    Awards at 2 institutions

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Boaz Pirie Levi.

Bryan Bentley Gore
Allen Institute
2
shared awards
Ed Lein
Allen Institute
2
shared awards
Franck K Kalume
Allen Institute
2
shared awards
John K Mich
Allen Institute
2
shared awards
Jonathan T Ting
Allen Institute
2
shared awards
Bryan Bentley Gore
Epicure Therapeutics, Inc.
1
shared award
John K Mich
Epicure Therapeutics, Inc.
1
shared award
Rong Guo
Epicure Therapeutics, Inc.
1
shared award

Explore further

Find collaborators for Boaz Pirie Levi

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →